Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study (Q34104404)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Blood-pressure reduction with LCZ696, a novel dual-acting inhibitor of the angiotensin II receptor and neprilysin: a randomised, double-blind, placebo-controlled, active comparator study (English)

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

0 references

Luis Miguel Ruilope

object named as

Luis Miguel Ruilope

1

0 references

author name string

Andrej Dukat

2

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Michael Böhm

3

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Yves Lacourcière

4

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Jianjian Gong

5

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Martin P Lefkowitz

6

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

language of work or name

0 references

publication date

16 March 2010

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

375

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

9722

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

1255-1266

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

Natriuretic peptides

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Biology of natriuretic peptides and their receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular biology of the natriuretic peptide system: implications for physiology and hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic inhibition of endopeptidase 24.11 in essential hypertension: evidence for enhanced atrial natriuretic peptide and angiotensin II

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of candoxatril and atrial natriuretic factor in healthy men. Effects on hemodynamics, sympathetic activity, heart rate variability, and endothelin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of neutral endopeptidase causes vasoconstriction of human resistance vessels in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Vasopeptidase inhibition: a double-edged sword?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Omapatrilat reduces pulse pressure and proximal aortic stiffness in patients with systolic hypertension: results of the conduit hemodynamics of omapatrilat international research study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Omapatrilat and enalapril in patients with hypertension: the Omapatrilat Cardiovascular Treatment vs. Enalapril (OCTAVE) trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of bradykinin metabolism inhibitors on evoked hypotension in rats: rank efficacy of enzymes associated with bradykinin-mediated angioedema

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Angioedema associated with angiotensin-converting enzyme inhibitor use: outcome after switching to a different treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Guidelines for management of hypertension: report of the fourth working party of the British Hypertension Society, 2004-BHS IV.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Combining multiple comparisons and modeling techniques in dose-response studies

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of the effects of omapatrilat and lisinopril on circulating neurohormones and cytokines in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparative effects of aliskiren-based and ramipril-based therapy on the renin system during long-term (6 months) treatment and withdrawal in patients with hypertension.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systolic blood pressure, pulse pressure and arterial stiffness as cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Systolic blood pressure, diastolic blood pressure, and pulse pressure as predictors of risk for congestive heart failure in the Framingham Heart Study

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Isolated systolic hypertension : prognostic information provided by pulse pressure

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Relation of pulse pressure and blood pressure reduction to the incidence of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2809%2961966-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(09)61966-8

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

31 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34104404&oldid=1539832175"